Shares of Kiniksa Pharmaceuticals, Ltd. KNSA declined 2.9% after the company said that its Phase 3 trial of mavrilimumab that is used for treatment of acute respirated syndrome caused due to COVID-19 failed to meet the primary efficacy point.Apple, Inc.’s AAPL shares fell 0.6% after the iPhone maker announced that it was closing its 12 New York City stores to indoor traffic owing to the spread of the Omicron variant of the coronavirus.Shares of Vipshop Holdings Limited VIPS tumbled 5.3% after Chinese e-commerce company cut down its current quarter revenue guidance citing its “latest view on the market and operational conditions.”Carnival Corporation & plc’s CCL shares fell 0.2% after investors considered that the CDC gave an indication that many of its cruise ships had reached “yellow” status on Dec 27, which means the reported cases of fresh coronavirus infections have reached the threshold for a CDC investigation. More Stock News: This Is Bigger than the iPhone! It could become the mother of all technological revolutions. Apple sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 77 billion devices by 2025, creating a $1.3 trillion market. Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 4 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2022.Click here for the 4 trades >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Apple Inc. (AAPL): Free Stock Analysis Report Carnival Corporation (CCL): Free Stock Analysis Report Vipshop Holdings Limited (VIPS): Free Stock Analysis Report Kiniksa Pharmaceuticals, Ltd. (KNSA): Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research